Study: 46% of people in US have hypertension under new guidelines | Study: Fewer people have ideal cardiovascular health | Studies show cardiovascular benefits of regular exercise
ADVERTISEMENT
May 24, 2018
PCNA SmartBrief
News about cardiovascular disease prevention and management
SIGN UP ⋅   FORWARD
Heart Health News
Study: 46% of people in US have hypertension under new guidelines
Hypertension treatment guidelines released last November by the American College of Cardiology and the American Heart Association mean about 46% of the US population would now be considered to have high blood pressure and 36% could be recommended for blood pressure medication, according to a study in JAMA Cardiology. If the guidelines were fully implemented, it could lead to 156,000 fewer deaths and 340,000 fewer heart attacks, strokes and other heart-related problems each year, the researchers predicted.
HealthDay News (5/23) 
LinkedIn Twitter Facebook Google+ Email
Study: Fewer people have ideal cardiovascular health
The number of people with an ideal cardiovascular health score, based on seven lifestyle and biological measures, decreased from 8.5% to 5.9% from 1991 to 2008, according to a study in the Journal of the American Heart Association. Researchers said the decrease was due mainly to poorer scores for body mass index, blood pressure, blood glucose and cholesterol.
HealthDay News/American Heart Association (5/17) 
LinkedIn Twitter Facebook Google+ Email
Studies show cardiovascular benefits of regular exercise
Individuals with a lifelong habit of exercise for at least half an hour each day, two or three times a week, had less stiff middle-sized arteries, while those who routinely exercised four to five times weekly had large, central arteries that were more youthful, compared with those who did not exercise, according to a study in The Journal of Physiology. A separate study in the journal Heart found that walking or riding a bicycle to work was linked to an 11% lower risk of ischemic heart disease and a 30% lower risk of death from heart disease.
HealthDay News (5/21),  Healio (free registration) (5/22) 
LinkedIn Twitter Facebook Google+ Email
Other News
Emerging Trends
Alogliptin does not raise CV event risk in diabetes, ACS patients, study finds
Researchers found that patients with type 2 diabetes and a recent acute coronary syndrome who received alogliptin did not have an increased risk of either first or recurrent cardiovascular events, compared with those on placebo. The findings in Clinical Cardiology, based on 5,380 patients from the Examination of Cardiovascular Outcomes with Alogliptin vs Standard of Care trial, revealed no significant difference in the number or type of CV events between the two groups.
Endocrinology Advisor (5/17) 
LinkedIn Twitter Facebook Google+ Email
Study supports extended testing intervals for warfarin patients
A study in the Journal of Thrombosis and Haemostasis that analyzed data from six anticoagulation clinics found extended intervals for international normalized ratio testing were safe for patients on warfarin who were considered stable. Patients with and without extended testing intervals had similar rates of major bleeding events and likelihood of having their next INR values be out of range.
Physician's Briefing/HealthDay News (5/23) 
LinkedIn Twitter Facebook Google+ Email
Nursing in the News
NPs' compensation up almost 30% over past 5 years
Nurse practitioners saw nearly 30% compensation growth over the past five years, according to a Medical Group Management Association survey. The increase was greater than that for primary care physicians, specialty physicians and physician assistants.
Health Exec (5/16) 
LinkedIn Twitter Facebook Google+ Email
PCNA Update
On-demand CE: Treating High-Risk Patients with Dyslipidemia
Learn the latest in lipid treatment guidelines and challenges in this hour-long, complimentary webinar. Earn 1.0 CE contact hours (0.5 pharmacology) while learning about the relevant guidelines, medications on the market and outcomes trials, as well as a case study demonstrating the application of lipid-lowering therapies in practice. Learn more.
LinkedIn Twitter Facebook Google+ Email
Learn more about PCNA:
Join PCNA | News | Clinical Tools | Conferences & Programs | Contact
  
  
Cleverness is serviceable for everything, sufficient for nothing.
Henri-Frederic Amiel,
philosopher and poet
LinkedIn Twitter Facebook Google+ Email
  
  
Sign Up
SmartBrief offers 200+ newsletters
Advertise
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Wynn Hansen
P: 202.470.1149
Partner Relations Manager  -  Madeline Sarver
Editor  -  Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2018 SmartBrief, Inc.®
Privacy Policy (updated May 25, 2018) |  Legal Information